Altered inotropic response to IGF-I in diabetic rat heart: influence of intracellular Ca2+and NO
- 1 September 1998
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 275 (3) , H823-H830
- https://doi.org/10.1152/ajpheart.1998.275.3.h823
Abstract
Normally, insulin-like growth factor I (IGF-I) exerts positive effects on cardiac growth and myocardial contractility, but resistance to its action has been reported in diabetes. This study was designed to determine whether IGF-I-induced myocardial contractile action is altered in diabetes as a result of an intrinsic alteration of contractile properties at the cellular level. Contractile responses to IGF-I were examined in left ventricular papillary muscles and ventricular myocytes from normal and short-term (5–7 days) streptozotocin-induced diabetic rats. Mechanical properties of muscles and myocytes were evaluated using a force transducer and an edge detector, respectively. Preparations were electrically stimulated at 0.5 Hz, and contractile properties analyzed include peak tension development (PTD) or peak twitch amplitude (PTA), time to peak contraction/shortening, and time to 90% relaxation/relengthening. Intracellular Ca2+transients were measured as fura 2 fluorescence intensity changes. IGF-I (1–500 ng/ml) caused a dose-dependent increase in PTD and PTA in preparations from normal but not diabetic animals. IGF-I did not alter time to peak contraction/shortening or time to 90% relaxation/relengthening. Pretreatment with the NO synthase inhibitor Nω-nitro-l-arginine methyl ester (100 μM) attenuated IGF-I-induced increases in PTD in normal myocardium but unmasked a positive inotropic action in diabetic animals. Pretreatment with Nω-nitro-l-arginine methyl ester blocked IGF-I-induced increases in PTA in single myocytes. Consistent with its inotropic actions on muscles and myocytes, IGF-I induced a dose-dependent increase in Ca2+transients in normal but not diabetic myocytes. These results suggest that the IGF-I-induced inotropic response is depressed in diabetes because of an intrinsic alteration at the myocyte level. Mechanisms underlying this alteration in IGF-I-induced myocardial response may be related to changes in intracellular Ca2+and/or NO production in diabetes.Keywords
This publication has 30 references indexed in Scilit:
- Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular PhysiologyHypertension, 1997
- Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols.The Journal of general physiology, 1996
- Diabetes Mellitus and Associated Hypertension, Vascular Disease, and NephropathyHypertension, 1995
- Positive inotropic effect of nitric oxide in myocardiumInternational Journal of Cardiology, 1995
- Chronic verapamil treatment attenuates the negative inotropic effect of ethanol in diabetic rat myocardiumCanadian Journal of Physiology and Pharmacology, 1994
- Myocardial infarct size and mortality in patients with non-insulin-dependent diabetes mellitusJournal of Internal Medicine, 1994
- Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cellsKidney International, 1994
- Impairment of Myocyte Contractility Following Coronary Artery Narrowing Is Associated with Activation of the Myocyte IGF1 Autocrine System, Enhanced Expression of Late Growth Related Genes, DNA Synthesis, and Myocyte Nuclear Mitotic Division in RatsExperimental Cell Research, 1993
- In-vivo regulation of messenger RNA encoding insulin-like growth factor-I (IGF-I) and its receptor by diabetes, insulin and IGF-I in rat muscleJournal of Endocrinology, 1992
- Insulin-like growth factors and insulin increase the contractility of neonatal rat cardiocytes in vitroBasic Research in Cardiology, 1988